Member Info for sir_digby

The Delta variant has a far higher R0 than the wild type that was prevalent last August at between 8/9 compared to 1/2 , it's a lot more transmissible hence able to seek out and infect those who don't enjoy the full efficacy of the vaccines and those who for reasons that escape me won't be vaccinated.

It's probably more transmissible among the vaccinated than the wild type was among unvaccinated, the vaccines however have greatly reduced incidences of severe illness and death.

So, a new assay and not even tweeted nevermind an rns. Because everything is going swimmingly. Perhaps they were holding it back to roll into a larger update, I hope so because the alternatives are they're incompetent or trolling us.

Suspect we'll see an operational update either tomorrow or Tuesday to bolster the presentation. They've said there'll be no new information released during it so based on the fact that they're 'excited' to give this presentation it can't be what's already in the public domain because the last 8 months have been distinctly underwhelming for shareholders.

Yes, presentations are available to watch later.

It's a highly transmissible It's airborne virus. Short of locking everyone in their cabins 24/7 there's nothing they can do to prevent transmission on what are effectively plague ships. Especially on the redneck flotilla that is carnival, never ever use the buffet or the pool.

I seem to remember a contract with them on bid stat for NCYT earlier this year. Fast accurate tests within an hour in their emergency Dept

BBC News - Huge gulf in hospitals' ability to contain Covid
https://www.bbc.co.uk/news/health-58186709

Do you have a link please trotters?

You can guarantee those questions will be asked at the AGM though and answers will be expected.

A vulture fund could move in here take a relatively small holding and force the company to go up for sale, the bod have an incredibly weak hand and no support. What worries me is that they will try to do an issue (possibly under the guise of a speculative raise for an acquisition while we're in dispute with the DHSC) to back door in supportive IIs at a bargain price and at the same time dilute us. Directors have no time for PIs we're merely an annoyance regardless of what they say.

There will be no sale though until the dispute is resolved at the very least, no one will even look at us until it's resolved.

What's interesting about ygen is their 80% uplift in Q1 since march, largely travel related I imagine. Bodes well for NCYT in the same period. If we're back supplying the NHS with promate as well, could be looking at very good numbers H2.

Post hoc ergo propter hoc - sentiment is in the toilet because the SP is, a couple of shareholders venting on Twitter is not the reason. Having read the responses to their tweet, not all are without merit, at any time NCYT can turn off responses if they wish, perhaps it would be more pertinent to ask why they don't.

There is no institutional interest here, literally none even @ 300p, that's the reason we're struggling, less than 3% of the company in institutional hands (ignoring vatels debt conversion). I know dog miners and oil explorers with worthless assets who are better supported. It is incredulous that a profitable company such as NCYT is in this position but here we are.

Then there's the fact that 50% of our 2020 revenue is in dispute, for reasons we have no idea why and will be the last to know. All the while we've been shorted mercilessly by entities who are far better connected and will know exactly what's gone on.

They need to put forward a stellar investment case next week or the AGM may be very uncomfortable, they not even be able to drum up enough votes to ratify the new CEO because trying to wrangle PIs is like trying to herd cats.

It isn't 3 * 10k buys, it's one with a cancellation + replacement.

Oriens1, if we don't get cases right down before kids go back to school in September we're going to find out. This could be a grim winter.

We've already seen early studies that show delta viral load is as high in vaccinated individuals as unvaxxed, with no mitigation measures in place we are going to see people facing infection with both covid and influenza.

Immunologist double jabbed Pfizer gets covid. There's zero chance we're going to reach herd immunity with the delta variant, how long before a variant emerges from delta with significant vaccine escape?

https://twitter.com/AlexRichter3/status/1424639317360713728?s=19

Those institutional figures are pitiful, really pitiful, even if you assume vatel still hold 4% yet aren't listed there. PIs effectively control over 90% of the company. They are really going to struggle to form a quorum for votes at the AGM unless they start communicating with shareholders.

I've literally never seen so little institutional interest in a profitable listed company. Can anyone name another?

@wilson63, quite possible that he deliberately excluded it but there it is sitting there being haggled over. Even the net figure is 20% of our mcap, infuriating.

Mr Anderson has ignored the fact that the DHSC currently has outstanding invoices totalling 73m, which after accounting for vat and the 19.8m provision adds another 39m to the cash position.

To be fair to the consumer, this is a joke. We need testing to protect the borders but scenes like this undermine the whole sector. I've said for months that there is nowhere near enough capacity in the private sector to service fit to fly and the likes of randox are being found wanting time and time again.

In the case of randox they've failed both the private and public sector but Tory donors so we plow on.

So abdx can't get them to pay a 6m bill for goods received and used but the DHSC has no problem shelling out 3.2bn through a middleman that has made arrangements so that he won't pay a penny in tax on it. Tis the Tory way.

Where's the press?

Yet strangely the NHS innova test was exempt from this validation process, nothing to hide there.